AION Labs, In Continued Partnership with BioMed X, Launches New Global Call for Applications: Identification of Active Small Molecules for Drug Discovery

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Author(s): PR Newswire
  • Source:
    PR Newswire US. 05/25/2023.
  • Additional Information
    • Alternate Title:
      AION-Labs-BioMed-X
    • Subject Terms:
      Germany; Israel; United States of America; New York
    • Abstract:
      Israel-based alliance of AstraZeneca, Merck, Pfizer, Teva, Israel Biotech Fund and Amazon Web Services (AWS) seeks global research and technology talent for new startup focused on: "AI-Powered Drug Discovery of New High-Affinity Small Molecules." [ABSTRACT FROM PUBLISHER]